Anwendung eines mRNA-basierten RSV-PreF-Impfstoffs bei älteren ErwachsenenUse of an mRNA-based RSV PreF vaccine in older adults

被引：0
|
作者：
Sibylle C. Mellinghoff
Oliver A. Cornely
Sirka Nitschmann
机构：
[1] Universitätsklinik Köln,Klinik I für Innere Medizin
来源：
Die Innere Medizin | 2024年 / 65卷 / 5期
关键词：
D O I：
10.1007/s00108-024-01696-1
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：527 / 529
页数：2
相关论文
共 7 条
  • [1] Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults
    Wilson, Eleanor
    Goswami, Jaya
    Baqui, Abdullah H.
    Doreski, Pablo A.
    Perez-Marc, Gonzalo
    Zaman, Khalequ
    Monroy, Jorge
    Duncan, Christopher J. A.
    Ujiie, Mugen
    Raemet, Mika
    Perez-Breva, Lina
    Falsey, Ann R.
    Walsh, Edward E.
    Dhar, Rakesh
    Wilson, Lauren
    Du, Jiejun
    Ghaswalla, Parinaz
    Kapoor, Archana
    Lan, Lan
    Mehta, Shraddha
    Mithani, Runa
    Panozzo, Catherine A.
    Simorellis, Alana K.
    Kuter, Barbara J.
    Schoedel, Florian
    Huang, Wenmei
    Reuter, Caroline
    Slobod, Karen
    Stoszek, Sonia K.
    Shaw, Christine A.
    Miller, Jacqueline M.
    Das, Rituparna
    Chen, Grace L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (24): : 2233 - 2244
  • [2] Use of an mRNA-based RSV-PreF vaccine in older adults
    Mellinghoff, Sibylle C.
    Cornely, Oliver A.
    Nitschmann, Sirka
    INNERE MEDIZIN, 2024, 65 (05): : 527 - 529
  • [3] SAFETY AND TOLERABILITY OF AN AD26.RSV.PREF-BASED VACCINE IN A PHASE 2B STUDY IN OLDER ADULTS
    Falsey, Ann
    Williams, Kristi
    Gymnopoulou, Efi
    Bart, Stephan
    Ervin, John
    De Paepe, Els
    Heijnen, Esther
    Comeaux, Christy
    INNOVATION IN AGING, 2021, 5 : 1045 - 1045
  • [4] ASSESSING THE COST-EFFECTIVENESS OF AN MRNA-BASED RSV VACCINE (MRNA-1345) AMONGST CANADIAN ADULTS AGED ≥60 YEARS
    Fust, K.
    Kohli, M.
    Ghaswalla, P.
    Jayasundara, K.
    Joshi, K.
    Van de Velde, N.
    Blake, M.
    VALUE IN HEALTH, 2024, 27 (06) : S89 - S90
  • [5] Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
    Shaw, Christine A.
    Essink, Brandon
    Harper, Charles
    Mithani, Runa
    Kapoor, Archana
    Dhar, Rakesh
    Wilson, Lauren
    Guo, Ruiting
    Panozzo, Catherine A.
    Wilson, Eleanor
    Simorellis, Alana K.
    Reuter, Caroline
    Stoszek, Sonia K.
    Chen, Grace L.
    Das, Rituparna
    Goswami, Jaya
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (03): : e647 - e656
  • [6] A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults
    Aliprantis, Antonios O.
    Shaw, Christine A.
    Griffin, Paul
    Farinola, Nicholas
    Railkar, Radha A.
    Cao, Xin
    Liu, Wen
    Sachs, Jeffrey R.
    Swenson, Christine J.
    Lee, Heather
    Cox, Kara S.
    Spellman, Daniel S.
    Winstead, Colleen J.
    Smolenov, Igor
    Lai, Eseng
    Zaks, Tal
    Espeseth, Amy S.
    Panther, Lori
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (05) : 1248 - 1261
  • [7] Safety and immunogenicity of an mRNA-based RSV vaccine in Japanese older adults aged ≥ 60 years: A phase 1, randomized, observer-blind, placebo-controlled trial
    Fitz-Patrick, David
    Mihara, Hanako
    Mills, Anthony
    Mithani, Runa
    Kapoor, Archana
    Dhar, Rakesh
    Wilson, Lauren
    Guo, Ruiting
    Simorellis, Alana K.
    Panozzo, Catherine A.
    Reuter, Caroline
    Wilson, Eleanor
    Chen, Grace L.
    Stoszek, Sonia K.
    Shaw, Christine A.
    Goswami, Jaya
    RESPIRATORY INVESTIGATION, 2024, 62 (06) : 1037 - 1043
1